EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prognostic significance of pretransplant 18 F ‐ FDG PET / CT metrics in relapsed/refractory diffuse large B‐cell lymphoma with partial response to salvage chemotherapy prior to autologous stem cell transplantation

Minseung Suh iD, Jaewon Hyung, Chan-Sik Park iD, Heounjeong Go, In Hye Song, Eun Jin Chae, Kyung Won Kim, Yoon Sei Lee, Minsu Kwon, Sang-Wook Lee iD, Jiwon Lee, Shin Kim und 4 weitere

British Journal of Haematology · 2025

DOI: 10.1111/bjh.70186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Minseung Suh und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Positron Emission Tomography Computed Tomography, Salvage Therapy, Fluorodeoxyglucose F18. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCIRD CDC HHS, Asan Institute for Life Sciences, Asan Institute for Life Sciences, Asan Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Relapsed/refractory diffuse large B‐cell lymphoma (R/R DLBCL) patients with partial response (PR) to salvage chemotherapy show heterogeneous outcomes after autologous stem cell transplantation (ASCT). Current visual positron emission tomography (PET) assessment inadequately identifies patients likely to benefit from transplantation. We retrospectively evaluated the prognostic value of semiquantitative metrics from interim 18 F‐fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F‐FDG PET/CT) in 50 R/R DLBCL patients with PR to salvage chemotherapy who underwent ASCT. PET/CT scans were analysed visually using the Deauville 5‐point scale and semiquantitatively using relative metrics measuring percentage maximum standardized uptake value (SUVmax) changes between baseline and interim scans (%ΔSUVmax‐variants) and absolute metrics including tumour‐to‐liver SUV ratios (SUVTLR). Cut‐off values were determined using quartile‐based analysis. With a median follow‐up of 107 months (range, 1.2–191.3), the median event‐free survival (EFS) was 9.87 months. Interim SUVTLR ≥4.2 was the predictor of inferior EFS (hazard ratio [HR] 1.25, p = 0.002), while the percentage change in the hottest lesion's SUVmax (%ΔSUVmax‐index) also showed prognostic significance (HR 0.91, p = 0.043). In contrast, visual Deauville scores at interim PET showed no prognostic difference between scores 4 and 5 ( p = 0.094 for EFS). Therefore, semiquantitative PET metrics, particularly interim SUVTLR of 4.2, can provide prognostic information beyond visual assessment in PR patients prior to ASCT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffusePositron Emission Tomography Computed TomographySalvage TherapyFluorodeoxyglucose F18Hematopoietic Stem Cell TransplantationHumansMaleFemaleMiddle AgedAdultAgedRetrospective StudiesPrognosisTransplantation, AutologousRecurrence

Stichwörter der Autor:innen

18F‐FDG PET/CTDeauville 5‐point scalediffuse large B‐cell lymphomaprognostic biomarkersemiquantitative analysistumour‐to‐liver SUV ratio

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Minseung Suh, Chan-Sik Park, Sang-Wook Lee, Dok Hyun Yoon

Förderung

  • NCIRD CDC HHS
  • Asan Institute for Life Sciences
  • Asan Institute for Life Sciences, Asan Medical Center

Zitieren

APA

Suh, M., Hyung, J., Park, C. S., Go, H., Song, I. H., Chae, E. J., Kim, K. W., Lee, Y. S., Kwon, M., Lee, S. W., Lee, J., Kim, S., Lee, K., Cho, H., Ryu, J. S., & Yoon, D. H. (2025). Prognostic significance of pretransplant 18 F ‐ FDG PET / CT metrics in relapsed/refractory diffuse large B‐cell lymphoma with partial response to salvage chemotherapy prior to autologous stem cell transplantation. British Journal of Haematology. https://doi.org/10.1111/bjh.70186

Vancouver

Suh M, Hyung J, Park CS, Go H, Song IH, Chae EJ, et al. Prognostic significance of pretransplant 18 F ‐ FDG PET / CT metrics in relapsed/refractory diffuse large B‐cell lymphoma with partial response to salvage chemotherapy prior to autologous stem cell transplantation. British Journal of Haematology. 2025. doi:10.1111/bjh.70186

BibTeX
@article{Suh2025,
  author = {Suh, Minseung and Hyung, Jaewon and Park, Chan-Sik and Go, Heounjeong and Song, In Hye and Chae, Eun Jin and Kim, Kyung Won and Lee, Yoon Sei and Kwon, Minsu and Lee, Sang-Wook and Lee, Jiwon and Kim, Shin and Lee, Kyoungmin and Cho, Hyungwoo and Ryu, Jin-Sook and Yoon, Dok Hyun},
  title = {Prognostic significance of pretransplant 18 F ‐ FDG PET / CT metrics in relapsed/refractory diffuse large B‐cell lymphoma with partial response to salvage chemotherapy prior to autologous stem cell transplantation},
  journal = {British Journal of Haematology},
  year = {2025},
  doi = {10.1111/bjh.70186}
}
Kostenlos starten →